Haleos Labs Limi

{
  "main_header": {
    "sid": 1002809,
    "name": "Haleos Labs Limi",
    "stock_name": "Haleos Labs Limi",
    "full_name": "Haleos Labs Limited",
    "name_url": "stocks-analysis/haleos-labs-limi",
    "exchange": 1,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,604.50",
    "chg": 120.7,
    "chgp": "8.13%",
    "dir": 1,
    "prev_price": "1,483.80",
    "mcapval": "453.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 540679,
    "symbol": "HALEOSLABS",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE320X01016",
    "curr_date": "May 06",
    "curr_time": "",
    "bse_nse_vol": "9.96 k",
    "exc_status": "Active",
    "traded_date": "May 06, 2026",
    "traded_date_str": "2026 05 06",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/haleos-labs-limi-1002809-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Broad-Based Technical Strength Lifts Haleos Labs Limited to 52-Week High of Rs 1620",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/haleos-labs-limited-hits-new-52-week-high-at-rs1620-3977885",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/HaleosLabsLimit_priceRelatedfactors_3977885.png",
        "date": "2026-05-06 12:10:16",
        "description": "Surging past its previous peaks, Haleos Labs Limited touched a new 52-week high of Rs 1620 on 6 May 2026, marking a significant milestone in its price momentum. This advance comes amid a backdrop of strong technical signals and outperformance relative to its sector and the broader market."
      },
      {
        "title": "Haleos Labs Limited is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/haleos-labs-limited-is-rated-hold-3977667",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/HaleosLabsLimit_mojoScore_3977667.png",
        "date": "2026-05-06 10:10:03",
        "description": "Haleos Labs Limited is rated 'Hold' by MarketsMOJO, with this rating last updated on 13 Apr 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 06 May 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Haleos Labs Limited to 52-Week High of Rs 1540",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/haleos-labs-limited-hits-new-52-week-high-at-rs1540-3967829",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/HaleosLabsLimit_priceRelatedfactors_3967829.png",
        "date": "2026-04-29 09:46:30",
        "description": "With a decisive surge to Rs 1540 on 29 Apr 2026, Haleos Labs Limited has marked a fresh 52-week high, reflecting robust momentum across multiple technical indicators and outperforming its sector peers."
      },
      {
        "title": "Haleos Labs Limited is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/haleos-labs-limited-is-rated-hold-3962237",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/HaleosLabsLimit_mojoScore_3962237.png",
        "date": "2026-04-25 10:10:03",
        "description": "Haleos Labs Limited is rated 'Hold' by MarketsMOJO, with this rating last updated on 13 April 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 April 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Haleos Labs Limited Upgraded to Hold as Technicals Improve and Valuation Attracts",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/haleos-labs-limited-upgraded-to-hold-as-technicals-improve-and-valuation-attracts-3945280",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/HaleosLabsLimit_mojoScore_3945280.png",
        "date": "2026-04-14 08:42:09",
        "description": "Haleos Labs Limited, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Sell to Hold as of 13 April 2026. This change reflects a nuanced improvement across technical indicators, valuation metrics, financial trends, and overall quality assessments, signalling a cautious but positive outlook for investors."
      },
      {
        "title": "Haleos Labs Downgraded to Sell Amid Technical Weakness and Valuation Concerns",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/haleos-labs-downgraded-to-sell-amid-technical-weakness-and-valuation-concerns-3939007",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/HaleosLabsLimit_mojoScore_3939007.png",
        "date": "2026-04-09 08:28:35",
        "description": "Haleos Labs Limited, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 8 April 2026. This change reflects a deterioration in technical indicators despite the company’s positive quarterly financial performance and long-term market-beating returns. Investors are advised to weigh the mixed signals from quality, valuation, financial trends, and technicals before making decisions."
      },
      {
        "title": "Haleos Labs Limited Upgraded to Hold as Technicals Improve and Valuation Attracts",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/haleos-labs-limited-upgraded-to-hold-as-technicals-improve-and-valuation-attracts-3933377",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/HaleosLabsLimit_mojoScore_3933377.png",
        "date": "2026-04-03 08:14:51",
        "description": "Haleos Labs Limited has seen its investment rating upgraded from Sell to Hold as of 2 April 2026, reflecting a notable shift in technical indicators and valuation metrics. Despite some lingering concerns over long-term fundamentals, the company’s recent financial performance and market behaviour have prompted a reassessment of its outlook within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Haleos Labs Limited Locks at Upper Circuit With 5% Gain — Buyers Queue, Sellers Absent",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/haleos-labs-limited-hits-upper-circuit-amid-strong-buying-pressure-3928914",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/HaleosLabsLimit_stocks_hitting_upper_circuit_3928914.png",
        "date": "2026-04-01 11:00:23",
        "description": "At Rs 1,253.80, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Haleos Labs Limited locked at its upper circuit of 5% on 1 Apr 2026, with buyers queuing and no sellers willing to part with shares."
      },
      {
        "title": "Haleos Labs Limited Downgraded to Sell Amid Mixed Financials and Technical Weakness",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/haleos-labs-limited-downgraded-to-sell-amid-mixed-financials-and-technical-weakness-3917690",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/HaleosLabsLimit_mojoScore_3917690.png",
        "date": "2026-03-26 08:13:14",
        "description": "Haleos Labs Limited, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 25 March 2026. This revision reflects a combination of deteriorating technical indicators, subdued financial trends, and valuation challenges despite some positive quarterly performance. The downgrade underscores growing caution among investors amid mixed signals across key assessment parameters."
      }
    ],
    "total": 442,
    "sid": "1002809",
    "stock_news_url": "https://www.marketsmojo.com/news/haleos-labs-limited-1002809"
  },
  "announcements": [
    {
      "details": "SMS Lifesciences India Limited has informed the Exchange regarding Board meeting held on November 14, 2019.",
      "source": "NSE",
      "caption": "SMS Lifesciences India Limited - Outcome of Board Meeting",
      "datetime": "15-Nov-2019"
    },
    {
      "details": "SMS Lifesciences India Limited has informed the Exchange regarding 'Update on Ranitidine HCL'.",
      "source": "NSE",
      "caption": "SMS Lifesciences India Limited - Updates",
      "datetime": "04-Nov-2019"
    },
    {
      "details": "SMS Lifesciences India Limited has informed the Exchange regarding 'Certificate under regulation 74(5) of SEBI(DP)Regulations,2018'.",
      "source": "NSE",
      "caption": "SMS Lifesciences India Limited - Updates",
      "datetime": "22-Oct-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Haleos Labs Limited has declared <strong>15%</strong> dividend, ex-date: 24 Sep 25",
          "dt": "2025-09-24",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Broad-Based Technical Strength Lifts Haleos Labs Limited to 52-Week High of Rs 1620

2026-05-06 12:10:16

Surging past its previous peaks, Haleos Labs Limited touched a new 52-week high of Rs 1620 on 6 May 2026, marking a significant milestone in its price momentum. This advance comes amid a backdrop of strong technical signals and outperformance relative to its sector and the broader market.

Read full news article

Haleos Labs Limited is Rated Hold

2026-05-06 10:10:03

Haleos Labs Limited is rated 'Hold' by MarketsMOJO, with this rating last updated on 13 Apr 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 06 May 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Broad-Based Technical Strength Lifts Haleos Labs Limited to 52-Week High of Rs 1540

2026-04-29 09:46:30

With a decisive surge to Rs 1540 on 29 Apr 2026, Haleos Labs Limited has marked a fresh 52-week high, reflecting robust momentum across multiple technical indicators and outperforming its sector peers.

Read full news article

Haleos Labs Limited is Rated Hold

2026-04-25 10:10:03

Haleos Labs Limited is rated 'Hold' by MarketsMOJO, with this rating last updated on 13 April 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 April 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Haleos Labs Limited Upgraded to Hold as Technicals Improve and Valuation Attracts

2026-04-14 08:42:09

Haleos Labs Limited, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Sell to Hold as of 13 April 2026. This change reflects a nuanced improvement across technical indicators, valuation metrics, financial trends, and overall quality assessments, signalling a cautious but positive outlook for investors.

Read full news article

Haleos Labs Downgraded to Sell Amid Technical Weakness and Valuation Concerns

2026-04-09 08:28:35

Haleos Labs Limited, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 8 April 2026. This change reflects a deterioration in technical indicators despite the company’s positive quarterly financial performance and long-term market-beating returns. Investors are advised to weigh the mixed signals from quality, valuation, financial trends, and technicals before making decisions.

Read full news article

Haleos Labs Limited Upgraded to Hold as Technicals Improve and Valuation Attracts

2026-04-03 08:14:51

Haleos Labs Limited has seen its investment rating upgraded from Sell to Hold as of 2 April 2026, reflecting a notable shift in technical indicators and valuation metrics. Despite some lingering concerns over long-term fundamentals, the company’s recent financial performance and market behaviour have prompted a reassessment of its outlook within the Pharmaceuticals & Biotechnology sector.

Read full news article

Haleos Labs Limited Locks at Upper Circuit With 5% Gain — Buyers Queue, Sellers Absent

2026-04-01 11:00:23

At Rs 1,253.80, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Haleos Labs Limited locked at its upper circuit of 5% on 1 Apr 2026, with buyers queuing and no sellers willing to part with shares.

Read full news article

Haleos Labs Limited Downgraded to Sell Amid Mixed Financials and Technical Weakness

2026-03-26 08:13:14

Haleos Labs Limited, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 25 March 2026. This revision reflects a combination of deteriorating technical indicators, subdued financial trends, and valuation challenges despite some positive quarterly performance. The downgrade underscores growing caution among investors amid mixed signals across key assessment parameters.

Read full news article

View All News